Cutler Group’s Q32 Bio QTTB Stock Holding History

Cutler Group’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-89	Closed	-$6K	–	6431
2020 Q4	$6K	Buy	89 +61	+218%	+$11.8K	﹤0.01%	3575
2020 Q3	$1K	Buy	+28	New	+$6.28K	﹤0.01%	4497

Other funds holding QTTB

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cutler Group's QTTB Position: Q4 2021 in Review

Cutler Group sold out of Q32 Bio (QTTB) in Q4 2021, closing a stake of 50 shares — an estimated $7K sold.

Cutler Group first reported a position in QTTB in Q4 2019 and held it in 7 quarters. The position peaked at $28K in Q4 2020. 120 funds tracked by Wall St. Rank hold QTTB as of Q4 2021.

Cutler Group reported no remaining Q32 Bio position as of Q4 2021 after selling out during the quarter.
Cutler Group sold 50 Q32 Bio shares in Q4 2021, an estimated $7K.
Cutler Group first reported a position in Q32 Bio in Q4 2019 and held it in 7 quarters.
Cutler Group's Q32 Bio position peaked at $28K in Q4 2020.
120 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2021.

Based on Cutler Group's 13F filing for Q4 2021, filed 18 Jan 2022.